Medical Science Liaison – Epilepsy & Rare Syndromes (SE)

UCB Inc.; Smyrna (GA); Hybrid; USD 156,000 - 204,000; Full time

Job summary

UCB Inc. is seeking a clinically experienced Medical Science Liaison (MSL) for the Southeast region, covering Georgia and South Carolina.

The role focuses on advancing understanding of epilepsy and rare syndromes, engaging with KOLs, investigators, and patient groups to support patient care in the local health ecosystem. The candidate will stay abreast of research, provide medical insights to strategies, and represent UCB at conferences while working in a hybrid environment with 60–80% travel in

Qualifications

• Doctorate (PhD, PharmD, MD, DPM, or DO) with minimum of 3 years' experience as an MSL.
• NP/PA with a minimum of 3 years' experience as an MSL or minimum of 3 years of direct clinical experience in relevant therapeutic area or 5 years in the pharmaceutical industry.

Responsibilities

• Stay current with research and clinical data related to epilepsy and rare syndromes.
• Execute targeted stakeholder engagement strategies to identify local needs and opportunities.
• Provide meaningful medical insights to support medical strategies and initiatives.
• Represent UCB at scientific conferences and educational events.
• Collaborate cross-functionally to enhance patient care and contribute to medical projects as needed.
• May lead/support other Medical Affairs projects or activities as assigned.

Skills

Scientific communication

Presentation skills

Active listening

Independent working

Cross-functional collaboration

Education

Doctorate (PhD/PharmD/MD/DPM/DO)

NP/PA with MSAL experience

Job description

UCB Inc. is seeking a clinically experienced Medical Science Liaison (MSL) for the Southeast region, covering Georgia and South Carolina.

The role focuses on advancing understanding of epilepsy and rare syndromes, engaging with KOLs, investigators, and patient groups to support patient care in the local health ecosystem. The candidate will stay abreast of research, provide medical insights to strategies, and represent UCB at conferences while working in a hybrid environment with 60–80% travel in